FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Novartis Updating Beovu Labeling Over Safety Signal

Novartis says it is seeking revised prescribing information with Beovu (brolucizumab) after confirming a safety signal involving retinal vasculitis an...

Human Drugs

Temporary Policy on PPE Used in Drug Compounding

FDA issues a guidance entitled Temporary Policy Regarding Non-Standard PPE Practices for Sterile Compounding by Pharmacy Compounders Not Registered as...

Medical Devices

Steris Gets EUA for N-95 Respirator Decontamination

FDA issues a second emergency use authorization for decontaminating compatible N95 or N95-equivalent respirators for reuse by health care workers in h...

Human Drugs

AstraZenecas Koselugo OKd for Pediatric Neurofibromatosis

FDA approves an AstraZeneca NDA for Koselugo (selumetinib) for treating of pediatric patients with neurofibromatosis type 1, a nervous system genetic ...

Medical Devices

Vapotherm Gets Breakthrough Status for Oxygen Assist

FDA grants Vapotherm a breakthrough device designation for its Oxygen Assist Module for use in the companys Precision Flow system.

Human Drugs

Guide on Human Research Protections During Covid-19

FDA directs industry to a new guidance from HHS Office for Human Research Protections entitled OHRP Guidance on Covid-19.

Human Drugs

DeGette Wants FDA Drug Hoarding Action

Rep. Donna DeGette calls on FDA to take several steps to ensure that patients who need hydroxychloroquine and chloroquine for approved indications can...

Medical Devices

Medtronic Gets Ventilator EUA

Medtronic describes several actions to increase its manufacturing of ventilators to help patients hospitalized with Covid-19.

Human Drugs

FDA Watching Serological Tests for False Claims

FDA says it is concerned that some firms are falsely claiming that their serological tests are FDA approved/authorized or that they can diagnose Covid...

Human Drugs

Fast Track for Non-opioid Pain Drug

FDA grants EicOsis a Fast Track designation for its lead drug candidate, EC5026, for treating neuropathic pain.